Literature DB >> 9778218

HPRT- mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis.

J L Cannons1, J Karsh, H C Birnboim, R Goldstein.   

Abstract

OBJECTIVE: To investigate the frequency and characteristics of hprt- mutant T lymphocytes in the peripheral blood and synovium of rheumatoid arthritis (RA) patients compared with controls, and to correlate these findings with disease parameters.
METHODS: An hprt- T cell assay was performed on blood and synovial samples from 93 RA patients, 8 osteoarthritis (OA) patients, and 19 control subjects. T cell clones were studied by flow cytometry and evaluated for fibronectin adhesion.
RESULTS: RA patients showed a 5-fold increase in the frequency of mutant T cells in the peripheral blood compared with that in control peripheral blood, and a further 10-fold increase in the mutant T cell frequency in synovial tissue. In OA patients, the synovium also had a significantly higher frequency of hprt- mutant T cells compared with the peripheral blood, but at a lower level than in the rheumatoid synovium. RA peripheral blood mutant T cell clones displayed elevated fibronectin adhesion and beta1 integrin expression, similar to that observed in the RA synovial T cell lines.
CONCLUSION: The origin of the mutated T cells in the peripheral blood of these patients appears to be the inflamed synovium of RA, and to a lesser extent, of OA, where the cells are exposed to a mitogenic and genotoxic environment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778218     DOI: 10.1002/1529-0131(199810)41:10<1772::AID-ART9>3.0.CO;2-C

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells.

Authors:  Cindy L Zuleger; Michael D Macklin; Bret L Bostwick; Qinglin Pei; Michael A Newton; Mark R Albertini
Journal:  J Immunol Methods       Date:  2010-12-21       Impact factor: 2.303

2.  Regulation of the Cell Cycle and Inflammatory Arthritis by the Transcription Cofactor LBH Gene.

Authors:  Shinji Matsuda; Deepa Hammaker; Katharyn Topolewski; Karoline J Briegel; David L Boyle; Steven Dowdy; Wei Wang; Gary S Firestein
Journal:  J Immunol       Date:  2017-08-14       Impact factor: 5.422

3.  Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model.

Authors:  J K Sandhu; H F Privora; G Wenckebach; H C Birnboim
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 4.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 5.  Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.

Authors:  Noah A Kaitz; Cindy L Zuleger; Peng Yu; Michael A Newton; Richard J Albertini; Mark R Albertini
Journal:  Mutat Res Rev Mutat Res       Date:  2022-03-11       Impact factor: 7.015

6.  Regional analysis of p53 mutations in rheumatoid arthritis synovium.

Authors:  Yuji Yamanishi; David L Boyle; Sanna Rosengren; Douglas R Green; Nathan J Zvaifler; Gary S Firestein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

7.  Somatic mutations and anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis: comment on the editorial by Levesque et al.

Authors:  Gary S Firestein
Journal:  Arthritis Rheum       Date:  2010-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.